Targeting the microRNA binding domain of argonaute 2: rational inhibitor design and study of mutation effects on protein-ligand interaction.

Abstract excerpt

Based on the accumulative evidences during recent decades, miRNAs have been found overexpressed in several human cancer types and also in Down syndrome patients, contributing to the neuropathology of Down syndrome. From this point of view, investigations on the structure and dynamic mechanisms related to the Argonaute 2 miRNAs binding in which silencing of the mRNA occurs, have inspired many clinical researchers...

Topics

Share this publication in a Topic to start or enrich a Post.

• Share to Ligands
• Share to MicroRNAs
• Share to Molecular Dynamics Simulation
• Share to Mutation